Iopamiro (Iopamidol)

Iopamiro, an iodinated contrast agent, is used in radiographic procedures that require enhanced visualization of vascular and organ structures.

• Angiography: provides high‑contrast images of blood vessels to aid diagnosis and interventional planning.
• Computed tomography (CT) imaging: improves delineation of soft‑tissue and vascular anatomy during CT scans.
• Urography: enhances visualization of the urinary tract for functional and structural assessment.
• Arthrography: facilitates detailed imaging of joint spaces and cartilage.
• Hysterosalpingography: highlights the uterine cavity and fallopian tubes for fertility evaluation.

• Iopamidol contains a high density of iodine atoms that absorb X‑ray photons, increasing attenuation of the X‑ray beam. When injected into the vascular system or body cavities, the iodine‑rich solution creates a radiopaque medium that outlines vessels, organs and cavities on imaging studies. Its osmotic properties promote rapid distribution and clearance, allowing high‑contrast images while maintaining a favorable safety profile.

Iopamiro may be associated with a range of adverse reactions, ranging from mild to severe.

Common Side Effects

• Warmth or flushing at the injection site.
• Mild nausea or vomiting.
• Transient headache.
• Metallic taste in the mouth.
• Mild itching or urticaria.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis) with respiratory distress.
• Acute kidney injury, especially in patients with pre‑existing renal impairment.
• Cardiovascular collapse or hypotension.
• Seizures or neurological disturbances.
• Persistent vomiting leading to dehydration.

Prior to administering Iopamiro, clinicians should observe several safety precautions to minimize risk.

• Assess renal function: evaluate serum creatinine and eGFR before use.
• Review allergy history: avoid in patients with known hypersensitivity to iodinated contrast.
• Hydration status: ensure adequate hydration to reduce nephrotoxicity risk.
• Concomitant nephrotoxic drugs: discontinue or adjust dosage of agents such as NSAIDs or aminoglycosides when possible.
• Pregnancy and lactation: use only if clearly needed, as safety data are limited.
• Store at controlled room temperature: keep the vial in the original packaging, protect from light and freeze, and store below 25 °C.

Iopamiro can interact with other medications, influencing its safety or efficacy.

Major Interactions (Avoid)

• Concurrent use of other iodinated contrast agents: may increase cumulative iodine load and risk of adverse reactions.
• High‑dose metformin in patients with renal impairment: risk of lactic acidosis; discontinue metformin before and after contrast administration.

Moderate Interactions (Monitor Closely)

• Nephrotoxic drugs (e.g., NSAIDs, amphotericin B): monitor renal function closely.
• Thyroid hormone therapy: iodine load may affect thyroid function tests.
• Beta‑blockers: may mask signs of anaphylactoid reactions.
• Diuretics: may exacerbate fluid shifts; assess volume status.
• ACE inhibitors or ARBs: consider temporary suspension in high‑risk renal patients.